Rocket Pharmaceuticals (9IP1.STU) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-0.36
-0.35
-0.35
-0.35

Details

Expected EPS
-0.34685336595000005
Actual EPS
-0.3581214
Surprise EPS
-0.01
Surprise Percent
+3.25%

Description

Rocket Pharmaceuticals (9IP1.STU) has reported earnings of -0.3581214 per share for Q2 2026.

0 Comments

Share your thoughts